Stuck? Enhancing Treatments for Anxiety and Depression With Dialectical Behavior Therapy

Jennifer L. Taitz, PsyD
Director, Dialectical Behavior Therapy Program
American Institute for Cognitive Therapy

Dr. Taitz explains how the skills and strategies learned in dialectical behavior therapy, or DBT, can help people who have anxiety and depression. Skills include mindfulness, emotion regulation, distress tolerance, and interpersonal effectiveness.

Learn more...

Conference Highlights

On the Cutting Edge of Wellness: Behavioral Medicine and Its Application to Anxiety and Depressive Disorders

Anxiety and depressive disorders are characterized by significant functional limitations and comorbid mental and physical health conditions that diminish quality of life and sense of well-being. Behavioral medicine, an interdisciplinary field combining medicine and psychology, provides increasingly popular evidence-based approaches to the remediation and healing of mental and physical health concerns and the emergence of wellness.

Be More Social

State
Georgia

Be More Social is a peer support group where people with Social Anxiety, Social Phobia and Excessive shyness can learn to improve Social Skills in a safe and confidential environment without being judged by others. It is your space to be yourself. Acceptance and friendship are given freely in this group.

College-Aged Adults Face Less Mental Health Stigma

College-aged adults (age 18–25) have more accepting views of mental health care than other adults, but they still see challenges when it comes to accessing care, according to results of a nationwide poll. The survey was conducted online among more than 2,000 adults, including 198 age 18–25, by Harris Poll on behalf of Anxiety and Depression Association of America (ADAA) and two partnering organizations.

Dose Timing of D-Cycloserine to Augment CBT for Social Anxiety Disorder

Eligibility Criteria

Male and female outpatients 18 or older:

  • With a primary psychiatric diagnosis (designated by the patient as the most important source of current distress) of social anxiety disorder as defined by DSM-5 criteria
  • A total score ≥ 60 on the LSAS.
  • Physical examination and laboratory findings without clinically significant abnormalities
  • Willingness and ability to participate in the informed consent process and comply with the requirements of the study protocol

 

Exclusion Criteria
  • A lifetime history of bipolar disorder, schizophrenia, psychosis, delusional disorders or obsessive-compulsive disorder; an eating disorder in the past 6 months; organic brain syndrome, mental retardation or other cognitive dysfunction that could interfere with capacity to engage in therapy; a history of substance or alcohol abuse or dependence (other than nicotine) in the last 6 months or othersie unable to commit to refraining from alcohol use during the acute period of study participation
  • PTSD within the past 6 months. Entry of patients with other mood or anxiety disorders will be permitted if the SAD is judged to be the predominant disorder, in order to increase accrual of a clinically relevant sample. Patients with significant suicidal ideation or who have enacted suicidal behaviors within 6 months prior to intake will be excluded from study participation and referred for appropriate clinical intervention
  • Patients must be off concurrent psychotropic medication (e.g., antidepressants, anxiolytics, beta blockers) for at least 2 weeks prior to initiation of randomized treatment
  • Significant personality dysfunction likely to interfere with study participation
  • Serious medical illness or instability for which hospitalization may be likely within the next year
  • Patients with a current or past history of seizures
  • Pregnant women, lactating women, and women of childbearing potential who are not using medically accepted forms of contraception (e.g., IUD, oral contraceptives, barrier devices, condoms and foam, or implanted progesterone rods stabilized for at least 3 months)
  • Any concurrent psychotherapy initiated within 3 months of baseline, or ongoing psychotherapy of any duration directed specifically toward treatment of SAD is excluded. Prohibited psychotherapy includes CBT or psychodynamic therapy focusing on exploring specific, dynamic causes of the phobic symptomatology and providing management skills. General supportive therapy initiated > 3 months prior is acceptable
  • Prior non-response to adequately-delivered exposure (i.e., as defined by the patient's report of receiving specific and regular exposure assignments as part of a previous treatment)
  • Patients with a history of head trauma causing loss of consciousness, seizure or ongoing cognitive impairment. Current use of isoniazid or ethionamide compounds
  • Insufficient command of the English language
State
Texas

This study aims to evaluate whether d-cycloserine (DCS) can enhance the effectiveness of cognitive-behavioral therapy (CBT) in improving treatment outcomes for social anxiety disorder, including whether the timing of the dosage is important for memory consolidation. Each patient’s participation will help investigators determine whether administering a dose of DCS before a therapy session will help the patient retain the new behaviors learned in session and therefore, reduce symptoms associated with social anxiety disorder.

PODCASTS

ADAA podcasts are presented by ADAA professional member experts on a wide variety of subjects related to anxiety, depression, OCD, PTSD, and other disorders. While the majority of the podcasts were recorded at past ADAA professional conferences with content geared toward mental health professionals, the information presented is highly relevant for both public and professional audiences. You can search (please see search option to the right of this page) by disorder or by population. The most recent additions to the podcast listing are those podcasts that appear at the top of this page. If your organization/company is interested in sponsoring an ADAA professional podcast, please contact Susan Gurley, ADAA Executive Director at: sgurley@adaa.org.
Category: Anxiety, Depression, OCD
Population: Adults
Category: Social Anxiety
Population: Adults
Cognitive Therapy
Category: Anxiety, OCD
Population: Adults
Cognitive Defusion
Category: Anxiety, OCD
Population: Adults
Category: Phobias
Population: Teens/Adolescents
Julie Wetherell, PhD
Category: Anxiety, Depression
Population: Older Adults (Seniors)
Darin Dougherty, MD
Category: OCD
Population: Adults
Virginia Runko, PhD
Category: Cognitive Behavioral Therapy (CBT), Insomnia
Population: Adults
Jennifer Taitz, PhD
Category: Anxiety, Depression, Dialectical Behavior Therapy (DBT)
Population: Adults
Phillip J. Seibell, MD
Category: Medication, OCD
Population: Adults
Category: Anxiety, Bipolar Disorder
Population: Adults
Category: Anxiety, OCD
Population: Families
AilsaRussell
Category: Autism Spectrum Disorders, OCD
Population: Adults
GailSteketee
Category: Hoarding
Population: Older Adults (Seniors)
PeggyRichter
Category: Cognitive Behavioral Therapy (CBT), OCD, Psychopharmacology
Population: Adults
StevenKurtz
Category: Selective Mutism
Population: Children
PatHarvey Podcast
Category: Dialectical Behavior Therapy (DBT)
Population: Children, Families, Teens/Adolescents
MarkReinecke
Category: Cognitive Behavioral Therapy (CBT), Depression, Suicide
Population: Teens/Adolescents
Jenny Yip
Category: Anxiety
Population: Children
JShannon
Category: Cognitive Behavioral Therapy (CBT), Social Anxiety
Population: Teens/Adolescents
Philip Muskin
Category: Anxiety, CAM (Complementary and Alternative Medicine), Depression
Population: Adults
BethSalcedoMD
Category: Anxiety, Depression, Weight
Population: Adults
Eken Jacobi
Category: Eating Disorders
Population: Children
KatharinaManassis
Category: School Refusal
Population: Children
Lydiard
Category: Depression, Insomnia, PTSD, Substance Abuse
Population: Adults
KatharinaManassis
Category: Anxiety
Population: Children, Families
KatharinePhillips
Category: DSM-5
Population: Adults
Martin Franklin
Category: Tourette Syndrome, Trichotillomania
Population: Children
CarolineDandaPhD
Category: Anxiety, Stomachaches
Population: Children
Lavie
Category: Anxiety, Cardio Health
Population: Adults
MelissaHunt
Category: Anxiety, IBS (Irritable Bowel Syndrome), Social Anxiety
Population: Adults
judithcohen
Category: PTSD
Population: Children
Neziroglu
Category: Depersonalization Disorder
Population: Adults
TrishFurer
Category: Death
Population: Adults, Clinicians
DennisGreenberger
Category: Anxiety
Population: Adults
BryantICAPPhoto
Category: PTSD, Traumatic Brain Injury
Population: Adults
Pollack
Category: Anxiety, Treatment Resistance
Population: Adults, Clinicians
CynthiaBulik
Category: Anxiety, Eating Disorders
Population: Adults
Michelle Craske
Category: Cognitive Behavioral Therapy (CBT)
Population: Adults
JohnWalkup
Category: Anxiety, Medication
Population: Children
MichaelOtto
Category: Medication
Population: Adults
Asmundson
Category: Health Anxiety
Population: Adults
Roberto Lewis-Fernandez, MD
Category: Anxiety, Depression, Espanol
Population: Adults
Margaret altemus
Category: Anxiety
Population: Women
MelindaStanley
Category: Anxiety
Population: Older Adults (Seniors)
Author photos
Category: Stress
Population: Adults
Karen Cassiday
Category: Anxiety, Exercise
Population: Adult Children, Adults, Older Adults (Seniors)
Pollard Alec
Category: Anxiety, OCD, Treatment Resistance
Population:
Phillips
Category: Body Dysmorphic Disorder (BDD)
Population: Adults
Reidwilson
Category: Anxiety
Population: Adults
Category: Anxiety, Cognitive Behavioral Therapy (CBT)
Population: Adults
Category: PTSD
Population: Adults
Category: Hoarding
Population: Adults
Category: Anxiety, Genetics
Population: Adults

VIDEOS

ADAA podcasts are presented by ADAA professional member experts on a wide variety of subjects related to anxiety, depression, OCD, PTSD, and other disorders. While the majority of the podcasts were recorded at past ADAA professional conferences with content geared toward mental health professionals, the information presented is highly relevant for both public and professional audiences. You can search (please see search option to the right of this page) by disorder or by population. The most recent additions to the podcast listing are those podcasts that appear at the top of this page. If your organization/company is interested in sponsoring an ADAA professional podcast, please contact Susan Gurley, ADAA Executive Director at: sgurley@adaa.org.